Author: Bouffet E. Philip T. Negrier C. Ffrench M. Frappaz D. Gentilhomme O. Gianella-Borradori A. Brunat-Mentigny M. Blay J.Y.
Publisher: Elsevier
ISSN: 0959-8049
Source: European Journal of Cancer, Vol.33, Iss.10, 1997-09, pp. : 1620-1626
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Louwerens M. Smorenburg C. Sparreboom A. Loos W.J. Verweij J. de Wit R.
European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. :
By Crul M. Rosing H. de Klerk G.J. Dubbelman R. Traiser M. Reichert S. Knebel N.G. Schellens J.H.M. Beijnen J.H. ten Bokkel Huinink W.W.
European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. :
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours
By Androulakis N. Kouroussis C. Mavroudis D. Kakolyris S. Souglakos J. Agelaki S. Kalbakis K. Malas K. Pallis A. Samonis G. Georgoulias V.
European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. :
By Awada A. Eskens F.A.L.M. Piccart M. Cutler D.L. van der Gaast A. Bleiberg H. Wanders J. Faber M.N. Statkevich P. Fumoleau P. Verweij J. for the EORTC Early Clinical Studies Group
European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. :
By Gerrits C.J.H. Burris H. Schellens J.H.M. Planting A.S.T. van den Burg M.E.L. Rodriguez G.I. van Beurden V. Loos W.J. Hudson I. Fields S. Verweij J. von Hoff D.D.
European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. :